Upjohn
New Zealand OKs Mylan & Upjohn Merger Subject To A Divestment
The New Zealand Commerce Commission has granted clearance for Mylan and Upjohn (a wholly owned subsidiary of Pfizer) to merge their global pharmaceutical businesses. The clearance is subject to a divestment of certain assets. In New Zealand, both parties compete to supply off-patent prescription medicines. This includes competing to win contracts to supply medicines that […]
Featured News
European Regulators Scrutinize $20 Billion Offshore Engineering Tie-Up
Jul 22, 2026 by
CPI
South Korea Faces Record Antitrust Case as KFTC Weighs $7.7 Billion Bond-Market Penalties
Jul 22, 2026 by
CPI
TikTok US Security Chief to Testify Before House Panel on China Concerns
Jul 22, 2026 by
CPI
Armani Challenges Italian Antitrust Fine as Regulators Intensify Scrutiny of Luxury Supply Chains
Jul 22, 2026 by
CPI
Google to Appeal Swedish Court’s Damages Award to Klarna
Jul 22, 2026 by
CPI
Antitrust Mix
Antitrust Chronicle® – Antitrust Compliance
Jul 20, 2026 by
CPI
Your Antitrust Compliance Program: A Strong Voice in Your Defense
Jul 20, 2026 by
Joe Murphy
Antitrust Compliance for the AI Pricing Era
Jul 20, 2026 by
Alejandra Uria & Andre Geverola
Race to Report: Antitrust Leniency in the Whistleblower Era
Jul 20, 2026 by
Brian R. Faerstein & Nicole H. Sprinzen
Antitrust-By-Design: Competition Compliance in Digital Markets
Jul 20, 2026 by
Marcos Drummond Malvar, Gabriela Costa Carvalho Forsman & Luciana Mendes